ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 197

Collapsing Glomerulopathy in Collagen Vascular-Like Disease

Rawad Nasr1, Christine Johns2 and Elie Gertner3, 1Rheumatology - Internal Medicine, University of Minnesota, Minneapolis, MN, 2Section of Nephrology, Regions Hospital, St Paul, MN, 3Section of Rheumatology, Regions Hospital and University of Minnesota Medical School, St. Paul, MN

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Antinuclear antibodies (ANA), Connective tissue diseases, proteinuria and renal disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases: Periodic Fever Syndromes

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Background:

Collapsing Glomerulopathy (CG) is an uncommon podocytopathy with distinct clinical and pathological characteristics. It is usually associated with HIV disease or parvovirus B19 infection. There are a few case reports of CG in association with well defined connective tissue diseases mainly SLE. The rheumatological literature does not describe patients with CG and marked serological abnormalities who do not have sufficient clinical findings to diagnose definite collagen vascular disease. 

Objective:

Our objective is to expand the spectrum of rheumatological disease that may accompany CG to include patients with marked serological abnormalities, but minimal clinical findings that do not meet criteria for definite collagen vascular disease.  These patients all appear to have a very similar mode of presentation and course. Rheumatologists should be aware of this condition and its association with marked serological abnormalities.

Methods:

A review of all kidney biopsies performed at Regions Hospital from 2004 till 2012 revealed four cases of CG not associated with other diseases. We conducted a chart review of these patients. These four cases were then compared with the sixteen cases of collagen vascular-like disease in the renal literature to construct a profile of patients with collagen vascular-like disease and CG.

Results:

Four patients (all non-Caucasian) were identified. Ages ranged from 29 to 51 years. All patients presented with massive proteinuria (approximately 20 grams / 24 hours) and renal insufficiency. None of the renal biopsies showed evidence of lupus nephritis, immune complex deposition or vasculitis. All had evidence of CG. All testing for HIV, parvovirus B19, and other known causes of CG were negative.

 

Age

Sex

Ethnicity

Clinical

Cr (mg/dl)

Proteinuria (gr/24 hr)

ANA

Other

Rx

Outcome

38

M

AA*

Arthralgias

Dry mouth

3.7

21

1:160

High titer Anti-RNP, IgG ACLA*

Prednisone, MMF*

Improved at 6 mo f/u

51

M

Cambodian

None

3.4

20

1:80

Low titer ds-DNA

Prednisone

On PD* after 3 mo

25

F

African

Alopecia

2.4

12

1:1280

High titer Anti-RNP, IgA/IgM ACLA*, ds-DNA

Prednisone, Cyclosporine, and Hydroxychloroquine

On HD* after 3 years

29

F

Hispanic

Headaches

7.6

Not done

1:640

High titer Anti MPO, low C3

Prednisone

On HD* at onset

* ACLA=Anti-cardiolipin Antibodies, PD= Peritoneal Dialysis, HD= Hemodialysis, AA= African American, MMF=Mycophenolate Mofetil

In comparison, the few cases of collagen vascular-like disease and CG in the renal literature also had marked proteinuria, renal insufficiency, and were treated with prednisone +/- immunomodulatory therapy like MMF. Most patients became dialysis dependent within two years of diagnosis (some sooner) despite initial response to steroids. 

Conclusion:

Rheumatologists may be asked to see patients with collagen vascular-like disease (minimal symptoms and marked serological abnormalities) with severe proteinuria and renal insufficiency due to CG. The presence of high titer antibodies suggests that immune activation may play a role in the podocytopathy of some patients with CG. Treatment with steroids and the agents described to date does not seem to be effective in the long term. Further definition of these patients and treatment trials are necessary.


Disclosure:

R. Nasr,
None;

C. Johns,
None;

E. Gertner,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/collapsing-glomerulopathy-in-collagen-vascular-like-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology